aluates Reports

$ 0.0

Automative

T-cell Engaging bsAbs Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: June 2024

Report Code: QYRE-Auto-6L10971

Global T cell engaging bsAbs Drugs Market Research Report 2022

BUY CHAPTERS

T-cell Engaging bsAbs Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-6L10971

Report

June 2024

Pages:85

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

Immunocore Ltd

T-cell Engaging bsAbs Drugs - Market Size

The global market for T-cell Engaging bsAbs Drugs was estimated to be worth US$ 650.5 million in 2023 and is forecast to a readjusted size of US$ 6817.9 million by 2030 with a CAGR of 39.2% during the forecast period 2024-2030

T-cell Engaging bsAbs Drugs - Market

Bispecific T-cell engager (BiTE) stands out as a novel subclass of T-cell engaging bsAbs with promising clinical results in the treatment of cancers.

The T-cell Bispecific Antibodies Drug market is primarily driven by the growing interest in immuno-oncology therapies and the potential of T-cell engaging bispecific antibodies to revolutionize cancer treatment. These innovative drugs are designed to redirect a patient's own T-cells to attack cancer cells by simultaneously binding to a tumor antigen and a T-cell receptor. This dual mechanism of action offers a novel approach to target and eliminate cancer cells, especially in hematologic malignancies and solid tumors. The success of recent clinical trials showcasing their efficacy has led to increased investment and research in this field. However, challenges such as complex manufacturing processes, potential side effects like cytokine release syndrome, and the need for patient-specific tumor antigens limit their widespread adoption. The competitive landscape also poses challenges as numerous biotech companies are entering this space, requiring established players to continuously innovate and differentiate their drug candidates. Addressing these challenges through rigorous safety evaluations, manufacturing advancements, and strategic partnerships will be crucial for the successful development and commercialization of T-cell Bispecific Antibodies Drugs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for T-cell Engaging bsAbs Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of T-cell Engaging bsAbs Drugs by region & country, by Type, and by Application.

The T-cell Engaging bsAbs Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding T-cell Engaging bsAbs Drugs.

Market Segmentation

Scope of T-cell Engaging bsAbs Drugs - Market Report

Report Metric	Details
Report Name	T-cell Engaging bsAbs Drugs - Market
Forecasted market size in 2030	US$ 6817.9 million
CAGR	39.2%
Forecasted years	2024 - 2030
Segment by Type:	Blincyto Kimmtrak
Segment by Application	Hematological Cancers Solid Tumors
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Immunocore
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of T-cell Engaging bsAbs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of T-cell Engaging bsAbs Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of T-cell Engaging bsAbs Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the T-cell Engaging bsAbs Drugs - Market size in 2030?

Ans: The T-cell Engaging bsAbs Drugs - Market size in 2030 will be US$ 6817.9 million.

Who are the main players in the T-cell Engaging bsAbs Drugs - Market report?

Ans: The main players in the T-cell Engaging bsAbs Drugs - Market are Amgen, Immunocore

What are the Application segmentation covered in the T-cell Engaging bsAbs Drugs - Market report?

Ans: The Applications covered in the T-cell Engaging bsAbs Drugs - Market report are Hematological Cancers, Solid Tumors

What are the Type segmentation covered in the T-cell Engaging bsAbs Drugs - Market report?

Ans: The Types covered in the T-cell Engaging bsAbs Drugs - Market report are Blincyto, Kimmtrak

1 Market Overview

1.1 T-cell Engaging bsAbs Drugs Product Introduction

1.2 Global T-cell Engaging bsAbs Drugs Market Size Forecast

1.2.1 Global T-cell Engaging bsAbs Drugs Sales Value (2019-2030)

1.2.2 Global T-cell Engaging bsAbs Drugs Sales Volume (2019-2030)

1.2.3 Global T-cell Engaging bsAbs Drugs Sales Price (2019-2030)

1.3 T-cell Engaging bsAbs Drugs Market Trends & Drivers

1.3.1 T-cell Engaging bsAbs Drugs Industry Trends

1.3.2 T-cell Engaging bsAbs Drugs Market Drivers & Opportunity

1.3.3 T-cell Engaging bsAbs Drugs Market Challenges

1.3.4 T-cell Engaging bsAbs Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global T-cell Engaging bsAbs Drugs Players Revenue Ranking (2023)

2.2 Global T-cell Engaging bsAbs Drugs Revenue by Company (2019-2024)

2.3 Global T-cell Engaging bsAbs Drugs Players Sales Volume Ranking (2023)

2.4 Global T-cell Engaging bsAbs Drugs Sales Volume by Company Players (2019-2024)

2.5 Global T-cell Engaging bsAbs Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers T-cell Engaging bsAbs Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers T-cell Engaging bsAbs Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of T-cell Engaging bsAbs Drugs

2.9 T-cell Engaging bsAbs Drugs Market Competitive Analysis

2.9.1 T-cell Engaging bsAbs Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by T-cell Engaging bsAbs Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-cell Engaging bsAbs Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Blincyto

3.1.2 Kimmtrak

3.2 Global T-cell Engaging bsAbs Drugs Sales Value by Type

3.2.1 Global T-cell Engaging bsAbs Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global T-cell Engaging bsAbs Drugs Sales Value, by Type (2019-2030)

3.2.3 Global T-cell Engaging bsAbs Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global T-cell Engaging bsAbs Drugs Sales Volume by Type

3.3.1 Global T-cell Engaging bsAbs Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global T-cell Engaging bsAbs Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global T-cell Engaging bsAbs Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global T-cell Engaging bsAbs Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hematological Cancers

4.1.2 Solid Tumors

4.2 Global T-cell Engaging bsAbs Drugs Sales Value by Application

4.2.1 Global T-cell Engaging bsAbs Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global T-cell Engaging bsAbs Drugs Sales Value, by Application (2019-2030)

4.2.3 Global T-cell Engaging bsAbs Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global T-cell Engaging bsAbs Drugs Sales Volume by Application

4.3.1 Global T-cell Engaging bsAbs Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global T-cell Engaging bsAbs Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global T-cell Engaging bsAbs Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global T-cell Engaging bsAbs Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global T-cell Engaging bsAbs Drugs Sales Value by Region

5.1.1 Global T-cell Engaging bsAbs Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global T-cell Engaging bsAbs Drugs Sales Value by Region (2019-2024)

5.1.3 Global T-cell Engaging bsAbs Drugs Sales Value by Region (2025-2030)

5.1.4 Global T-cell Engaging bsAbs Drugs Sales Value by Region (%), (2019-2030)

5.2 Global T-cell Engaging bsAbs Drugs Sales Volume by Region

5.2.1 Global T-cell Engaging bsAbs Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2019-2024)

5.2.3 Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2025-2030)

5.2.4 Global T-cell Engaging bsAbs Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global T-cell Engaging bsAbs Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

5.4.2 North America T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

5.5.2 Europe T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

5.7.2 South America T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value

6.2.1 Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.3.2 United States T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.4.2 Europe T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.5.2 China T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.6.2 Japan T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.7.2 South Korea T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India T-cell Engaging bsAbs Drugs Sales Value, 2019-2030

6.9.2 India T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India T-cell Engaging bsAbs Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Amgen

7.1.1 Amgen Company Information

7.1.2 Amgen Introduction and Business Overview

7.1.3 Amgen T-cell Engaging bsAbs Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Amgen T-cell Engaging bsAbs Drugs Product Offerings

7.1.5 Amgen Recent Development

7.2 Immunocore

7.2.1 Immunocore Company Information

7.2.2 Immunocore Introduction and Business Overview

7.2.3 Immunocore T-cell Engaging bsAbs Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Immunocore T-cell Engaging bsAbs Drugs Product Offerings

7.2.5 Immunocore Recent Development

8 Industry Chain Analysis

8.1 T-cell Engaging bsAbs Drugs Industrial Chain

8.2 T-cell Engaging bsAbs Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 T-cell Engaging bsAbs Drugs Sales Model

8.5.2 Sales Channel

8.5.3 T-cell Engaging bsAbs Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

Immunocore Ltd

List of Tables

Table 1. T-cell Engaging bsAbs Drugs Market Trends

Table 2. T-cell Engaging bsAbs Drugs Market Drivers & Opportunity

Table 3. T-cell Engaging bsAbs Drugs Market Challenges

Table 4. T-cell Engaging bsAbs Drugs Market Restraints

Table 5. Global T-cell Engaging bsAbs Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global T-cell Engaging bsAbs Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global T-cell Engaging bsAbs Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global T-cell Engaging bsAbs Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market T-cell Engaging bsAbs Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers T-cell Engaging bsAbs Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers T-cell Engaging bsAbs Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of T-cell Engaging bsAbs Drugs

Table 13. Global T-cell Engaging bsAbs Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-cell Engaging bsAbs Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global T-cell Engaging bsAbs Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global T-cell Engaging bsAbs Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global T-cell Engaging bsAbs Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global T-cell Engaging bsAbs Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global T-cell Engaging bsAbs Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global T-cell Engaging bsAbs Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global T-cell Engaging bsAbs Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global T-cell Engaging bsAbs Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global T-cell Engaging bsAbs Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global T-cell Engaging bsAbs Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global T-cell Engaging bsAbs Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global T-cell Engaging bsAbs Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global T-cell Engaging bsAbs Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global T-cell Engaging bsAbs Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global T-cell Engaging bsAbs Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global T-cell Engaging bsAbs Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global T-cell Engaging bsAbs Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global T-cell Engaging bsAbs Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global T-cell Engaging bsAbs Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global T-cell Engaging bsAbs Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global T-cell Engaging bsAbs Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global T-cell Engaging bsAbs Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global T-cell Engaging bsAbs Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global T-cell Engaging bsAbs Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global T-cell Engaging bsAbs Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global T-cell Engaging bsAbs Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global T-cell Engaging bsAbs Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global T-cell Engaging bsAbs Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global T-cell Engaging bsAbs Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global T-cell Engaging bsAbs Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global T-cell Engaging bsAbs Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global T-cell Engaging bsAbs Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global T-cell Engaging bsAbs Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Amgen Company Information

Table 58. Amgen Introduction and Business Overview

Table 59. Amgen T-cell Engaging bsAbs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Amgen T-cell Engaging bsAbs Drugs Product Offerings

Table 61. Amgen Recent Development

Table 62. Immunocore Company Information

Table 63. Immunocore Introduction and Business Overview

Table 64. Immunocore T-cell Engaging bsAbs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Immunocore T-cell Engaging bsAbs Drugs Product Offerings

Table 66. Immunocore Recent Development

Table 67. Key Raw Materials Lists

Table 68. Raw Materials Key Suppliers Lists

Table 69. T-cell Engaging bsAbs Drugs Downstream Customers

Table 70. T-cell Engaging bsAbs Drugs Distributors List

Table 71. Research Programs/Design for This Report

Table 72. Key Data Information from Secondary Sources

Table 73. Key Data Information from Primary Sources

List of Figures

Figure 1. T-cell Engaging bsAbs Drugs Product Picture

Figure 2. Global T-cell Engaging bsAbs Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global T-cell Engaging bsAbs Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global T-cell Engaging bsAbs Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. T-cell Engaging bsAbs Drugs Report Years Considered

Figure 7. Global T-cell Engaging bsAbs Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global T-cell Engaging bsAbs Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by T-cell Engaging bsAbs Drugs Revenue in 2023

Figure 10. T-cell Engaging bsAbs Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Blincyto Picture

Figure 12. Kimmtrak Picture

Figure 13. Global T-cell Engaging bsAbs Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global T-cell Engaging bsAbs Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global T-cell Engaging bsAbs Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global T-cell Engaging bsAbs Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global T-cell Engaging bsAbs Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hematological Cancers

Figure 19. Product Picture of Solid Tumors

Figure 20. Global T-cell Engaging bsAbs Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global T-cell Engaging bsAbs Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global T-cell Engaging bsAbs Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global T-cell Engaging bsAbs Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global T-cell Engaging bsAbs Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 26. North America T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. South America T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. South America T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa T-cell Engaging bsAbs Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa T-cell Engaging bsAbs Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions T-cell Engaging bsAbs Drugs Sales Volume (%), (2019-2030)

Figure 37. United States T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 39. United States T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 43. China T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. China T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. China T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. India T-cell Engaging bsAbs Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. India T-cell Engaging bsAbs Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. India T-cell Engaging bsAbs Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. T-cell Engaging bsAbs Drugs Industrial Chain

Figure 59. T-cell Engaging bsAbs Drugs Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions